---
title: "42C.SG (42C.SG) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/42C.SG/news.md"
symbol: "42C.SG"
name: "42C.SG"
parent: "https://longbridge.com/en/quote/42C.SG.md"
datetime: "2026-05-12T16:56:04.759Z"
locales:
  - [en](https://longbridge.com/en/quote/42C.SG/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/42C.SG/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/42C.SG/news.md)
---

# 42C.SG (42C.SG) — Related News

### [iX Biopharma's consumer goods business undergoes internal restructuring | Lianhe Zaobao](https://longbridge.com/en/news/285922280.md)
*2026-05-11T10:22:19.000Z*
> Singapore biopharmaceutical company iX Biopharma announced an internal restructuring of its consumer goods business, wit

### [iX Biopharma Wins Conditional SGX Nod for New Share Placement](https://longbridge.com/en/news/284790085.md)
*2026-04-30T14:11:45.000Z*
> iX Biopharma Ltd. has received conditional approval from the Singapore Exchange for the issuance of 1,349,434 new ordina

### [iX Biopharma gets SGX nod to list 75.8 million shares in $6m placement](https://longbridge.com/en/news/276426356.md)
*2026-02-20T08:57:28.000Z*
> iX Biopharma Ltd. has received approval from the Singapore Exchange for the listing of up to 75.8 million new shares in 

### [iX Biopharma narrows losses in H1 FY 2026 despite 14% fall in revenue](https://longbridge.com/en/news/275366004.md)
*2026-02-09T21:39:33.000Z*
> iX Biopharma Ltd. reported a narrowed net loss of $2.1 million for H1 FY 2026, down from $6.3 million in H1 FY 2025, des

### [iX Biopharma to raise at least $5m via OCBC share placement](https://longbridge.com/en/news/263187883.md)
*2025-10-29T00:50:57.000Z*
> iX Biopharma Ltd plans to raise at least $5 million through a share placement with OCBC, targeting institutional and acc